MIR129-2 Gene

HGNC Family Non-coding RNAs
Name microRNA 129-2
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMicroRNA‐129, derived in part from the MIR129‑2 locus, has emerged as a pivotal tumor suppressor whose expression is frequently lost in diverse epithelial malignancies. Epigenetic silencing via hypermethylation of its CpG island has been reported in endometrial, esophageal, gastric, and hepatocellular carcinomas, resulting in the de‐repression of oncogenes such as SOX4 and cell cycle regulators like CDK6. Such molecular changes not only promote tumor growth but also correlate with aggressive clinical behavior and poorer patient survival."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMechanistic studies have demonstrated that miR‑129 exerts its tumor‐suppressive effects by directly targeting key molecules that drive proliferation, inhibit apoptosis, and promote migration and invasion. For example, miR‑129 suppresses the anti‐apoptotic protein BCL2, cell cycle promoters such as CDK6 and ROCK1, and oncogenic mediators including ETS1, YAP/TAZ, and MMP9. In various cancers—including colorectal, lung, breast, prostate, and hepatocellular carcinomas—restoration of miR‑129 levels reverses epithelial–mesenchymal transition and chemoresistance, ultimately reducing metastatic potential. These findings underscore the therapeutic promise of re‐establishing miR‑129 function in tumors."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "28"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its role in tumor suppression, miR‑129 also shows considerable promise as a diagnostic and prognostic biomarker. Altered miR‑129 levels have been detected in readily accessible body fluids—such as gastric juice, peripheral blood mononuclear cells, and exosomes—and correlate with disease status in diverse settings including gastric and prostate cancers, as well as in non‐malignant conditions like epilepsy, intervertebral disc degeneration, and heart failure. These findings support its potential use in noninvasive screening and the monitoring of disease progression."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "29", "end_ref": "35"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nThe biological function of miR‑129 is further fine‐tuned by a complex network of long non-coding and circular RNAs that act as molecular sponges, thereby modulating its availability to target critical oncogenic pathways. In multiple cancer types—including ovarian and cervical carcinomas—lncRNAs such as UCA1, SNHG12, PCAT‑1, FGD5‑AS1, and DARS‑AS1, as well as circular RNAs like circRAB11FIP1 and circASH2L, bind to miR‑129 and abrogate its suppressive effects. In parallel, strategies employing exosome‑mediated delivery of miR‑129 have been shown to restore its function and inhibit tumor progression, highlighting innovative avenues for therapeutic intervention."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "36", "end_ref": "38"}, {"type": "fg_f", "ref": "28"}, {"type": "fg_fs", "start_ref": "39", "end_ref": "42"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Yi-Wen Huang, Joseph C Liu, Daniel E Deatherage, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-09-1499"}], "href": "https://doi.org/10.1158/0008-5472.CAN-09-1499"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19887623"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19887623"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Ruizhe Shen, Shen Pan, Shengjian Qi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2010.03.121"}], "href": "https://doi.org/10.1016/j.bbrc.2010.03.121"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20331975"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20331975"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Xiangmei Chen, Ling Zhang, Ting Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Methylation-mediated repression of microRNA 129-2 enhances oncogenic SOX4 expression in HCC."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Liver Int (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/liv.12097"}], "href": "https://doi.org/10.1111/liv.12097"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23402613"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23402613"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Kwan-Yeung Wong, Rita Lok-Hay Yim, Yok-Lam Kwong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic inactivation of the MIR129-2 in hematological malignancies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hematol Oncol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1756-8722-6-16"}], "href": "https://doi.org/10.1186/1756-8722-6-16"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23406679"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23406679"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Chang-Yi Lu, Kai-Yuan Lin, Meng-Tsung Tien, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Frequent DNA methylation of MiR-129-2 and its potential clinical implication in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Chromosomes Cancer (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/gcc.22059"}], "href": "https://doi.org/10.1002/gcc.22059"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23580407"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23580407"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Min Kang, Yumei Li, Wenqi Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-129-2 suppresses proliferation and migration of esophageal carcinoma cells through downregulation of SOX4 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2013.1384"}], "href": "https://doi.org/10.3892/ijmm.2013.1384"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23677061"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23677061"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Xiuchong Yu, Haojun Song, Tian Xia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Growth inhibitory effects of three miR-129 family members on gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2013.09.048"}], "href": "https://doi.org/10.1016/j.gene.2013.09.048"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24055727"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24055727"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Yanping Gao, Bing Feng, Siqi Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-129 in Human Cancers: from Tumorigenesis to Clinical Treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000447913"}], "href": "https://doi.org/10.1159/000447913"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27802440"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27802440"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Junjie Wu, Jun Qian, Chun Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-129 regulates cell proliferation by downregulating Cdk6 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/cc.9.9.11535"}], "href": "https://doi.org/10.4161/cc.9.9.11535"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20404570"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20404570"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "M Karaayvaz, H Zhai, J Ju "}, {"type": "b", "children": [{"type": "t", "text": "miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2013.193"}], "href": "https://doi.org/10.1038/cddis.2013.193"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23744359"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23744359"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Danping Wang, Lin Luo, Junming Guo "}, {"type": "b", "children": [{"type": "t", "text": "miR-129-1-3p inhibits cell migration by targeting BDKRB2 in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-014-0098-1"}], "href": "https://doi.org/10.1007/s12032-014-0098-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25008064"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25008064"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Xin Hua Long, Yun Fei Zhou, Ai Fen Peng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Demethylation-mediated miR-129-5p up-regulation inhibits malignant phenotype of osteogenic osteosarcoma by targeting Homo sapiens valosin-containing protein (VCP)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-014-3021-7"}], "href": "https://doi.org/10.1007/s13277-014-3021-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25566966"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25566966"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Jun Li, Haiying Wang, Honggang Ke, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-129 regulates MMP9 to control metastasis of non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-3247-z"}], "href": "https://doi.org/10.1007/s13277-015-3247-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25716201"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25716201"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Guosheng Tan, Xinping Cao, Qiangsheng Dai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.3254"}], "href": "https://doi.org/10.18632/oncotarget.3254"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25895125"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25895125"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Ning Ma, Fan Chen, Shun-Li Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-129-5p inhibits hepatocellular carcinoma cell metastasis and invasion via targeting ETS1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2015.04.075"}], "href": "https://doi.org/10.1016/j.bbrc.2015.04.075"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25912876"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25912876"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yingying Xiao, Xiaoxia Li, Haoli Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic regulation of miR-129-2 and its effects on the proliferation and invasion in lung cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.12597"}], "href": "https://doi.org/10.1111/jcmm.12597"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26081366"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26081366"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Yue Yu, Ying Zhao, Xiao-Hu Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.5406"}], "href": "https://doi.org/10.18632/oncotarget.5406"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26460733"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26460733"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Irene V Bijnsdorp, Jasmina Hodzic, Tonny Lagerweij, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.7572"}], "href": "https://doi.org/10.18632/oncotarget.7572"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26918338"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26918338"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Xiaofeng Tang, Jianjun Tang, Xia Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of miR-129-2 by promoter hypermethylation regulates breast cancer cell proliferation and apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2016.4647"}], "href": "https://doi.org/10.3892/or.2016.4647"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26935022"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26935022"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Zhikui Liu, Changwei Dou, Bowen Yao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.9377"}], "href": "https://doi.org/10.18632/oncotarget.9377"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27191994"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27191994"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Bo Ra You, Woo Hyun Park "}, {"type": "b", "children": [{"type": "t", "text": "Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Carcinog (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mc.22701"}], "href": "https://doi.org/10.1002/mc.22701"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28667779"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28667779"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Song Xu, Jingping Ge, Zhengyu Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2017.10.037"}], "href": "https://doi.org/10.1016/j.biopha.2017.10.037"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29035829"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29035829"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Chaofan Han, Wenbo Wang "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-129-5p suppresses cell proliferation, migration and invasion via targeting ROCK1 in osteosarcoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2018.8374"}], "href": "https://doi.org/10.3892/mmr.2018.8374"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29328417"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29328417"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Xiqian Wang, Jing Li, Xiao Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-129 inhibits tumor growth and potentiates chemosensitivity of neuroblastoma by targeting MYO10."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2018.04.153"}], "href": "https://doi.org/10.1016/j.biopha.2018.04.153"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29864913"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29864913"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Qi Liu, Jianwu Jiang, Yang Fu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-129-5p functions as a tumor suppressor in gastric cancer progression through targeting ADAM9."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2018.05.105"}], "href": "https://doi.org/10.1016/j.biopha.2018.05.105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29879625"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29879625"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Jingyi Cao, Qichao Wang, Gang Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-129-5p inhibits gemcitabine resistance and promotes cell apoptosis of bladder cancer cells by targeting Wnt5a."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int Urol Nephrol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11255-018-1959-x"}], "href": "https://doi.org/10.1007/s11255-018-1959-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30117016"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30117016"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Xu Guo, Haozhe Piao, Ye Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of microRNA-129-5p in glioblastoma inhibits cell proliferation, migration, and colony-forming ability by targeting ZFP36L1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bosn J Basic Med Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.17305/bjbms.2019.4503"}], "href": "https://doi.org/10.17305/bjbms.2019.4503"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31999936"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31999936"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Xianjuan Shen, Shan Kong, Qian Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PCAT-1 promotes cell growth by sponging miR-129 via MAP3K7/NF-κB pathway in multiple myeloma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.15035"}], "href": "https://doi.org/10.1111/jcmm.15035"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32048803"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32048803"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Xing Yu, Lin Luo, Yibo Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gastric juice miR-129 as a potential biomarker for screening gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-012-0365-y"}], "href": "https://doi.org/10.1007/s12032-012-0365-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23307240"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23307240"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Song Xu, Xiao-Ming Yi, Wen-Quan Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2015)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26823749"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26823749"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Yuqiang Sun, Xiaofeng Wang, Zeyang Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of microRNA-129-2-3p and microRNA-935 in plasma and brain tissue of human refractory epilepsy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epilepsy Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.eplepsyres.2016.09.016"}], "href": "https://doi.org/10.1016/j.eplepsyres.2016.09.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27689807"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27689807"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Sweta Ramachandran, Alexander Lowenthal, Carissa Ritner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plasma microvesicle analysis identifies microRNA 129-5p as a biomarker of heart failure in univentricular heart disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0183624"}], "href": "https://doi.org/10.1371/journal.pone.0183624"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28859128"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28859128"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Weijie Yang, Ping Sun "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of microRNA-129-5p increases the risk of intervertebral disc degeneration by promoting the apoptosis of nucleus pulposus cells via targeting BMP2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.29274"}], "href": "https://doi.org/10.1002/jcb.29274"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31436339"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31436339"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Yi Wan, Zhi-Quan Yang "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA NEAT1 affects inflammatory response by targeting miR-129-5p and regulating Notch signaling pathway in epilepsy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384101.2020.1711578"}], "href": "https://doi.org/10.1080/15384101.2020.1711578"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31948324"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31948324"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Min Qiu, Da Liu, Qin Fu "}, {"type": "b", "children": [{"type": "t", "text": "MiR-129-5p shuttled by human synovial mesenchymal stem cell-derived exosomes relieves IL-1β induced osteoarthritis via targeting HMGB1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Life Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.lfs.2020.118987"}], "href": "https://doi.org/10.1016/j.lfs.2020.118987"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33417958"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33417958"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Junrong Wang, Cong Ye, Junbao Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.05.104"}], "href": "https://doi.org/10.1016/j.bbrc.2018.05.104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29777711"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29777711"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "D Sun, X-H Fan "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA SNHG12 accelerates the progression of ovarian cancer via absorbing miRNA-129 to upregulate SOX4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201903_17378"}], "href": "https://doi.org/10.26355/eurrev_201903_17378"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30964158"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30964158"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "W Zheng, X Tian, L Cai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201912_19683"}], "href": "https://doi.org/10.26355/eurrev_201912_19683"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31841198"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31841198"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Zhanqin Zhang, Hongtao Zhu, Jianguo Hu "}, {"type": "b", "children": [{"type": "t", "text": "CircRAB11FIP1 promoted autophagy flux of ovarian cancer through DSC1 and miR-129."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-021-03486-1"}], "href": "https://doi.org/10.1038/s41419-021-03486-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33637694"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33637694"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Xia Li, Meiting Qu, Jie Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CircASH2L facilitates tumor-like biologic behaviours and inflammation of fibroblast-like synoviocytes via miR-129-5p/HIPK2 axis in rheumatoid arthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Orthop Surg Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13018-021-02432-3"}], "href": "https://doi.org/10.1186/s13018-021-02432-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33964939"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33964939"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Guokun Liu, Xuan Du, Li Xiao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activation of FGD5-AS1 Promotes Progression of Cervical Cancer through Regulating BST2 to Inhibit Macrophage M1 Polarization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2021/5857214"}], "href": "https://doi.org/10.1155/2021/5857214"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34692852"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34692852"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Yong Ji, Jianxiang Ji, Hongming Yin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosomes derived from microRNA-129-5p-modified tumor cells selectively enhanced suppressive effect in malignant behaviors of homologous colon cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.2004981"}], "href": "https://doi.org/10.1080/21655979.2021.2004981"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34775889"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34775889"}]}]}]}
Synonyms MIR-129-2, MIRN129-2
NCBI Gene ID 406918
API
Download Associations
Predicted Functions View MIR129-2's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR129-2's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR129-2's ARCHS4 Predicted Functions.

Functional Associations

MIR129-2 has 721 functional associations with biological entities spanning 6 categories (molecular profile, functional term, phrase or reference, chemical, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 19 datasets.

Click the + buttons to view associations for MIR129-2 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR129-2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR129-2 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MIR129-2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR129-2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR129-2 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR129-2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR129-2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing MIR129-2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with MIR129-2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MIR129-2 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of MIR129-2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of MIR129-2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
IMPC Knockout Mouse Phenotypes phenotypes of mice caused by MIR129-2 gene knockout from the IMPC Knockout Mouse Phenotypes dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR129-2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR129-2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by MIR129-2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR129-2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR129-2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
WikiPathways Pathways 2014 pathways involving MIR129-2 protein from the Wikipathways Pathways 2014 dataset.